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Abstract
Background Laparoscopic cholecystectomy is considered
nowadays as the standard management of acute cholecys-
titis (AC). However, results from multicentric studies in the
general surgical community are still lacking.
Methods A prospective multicenter survey of surgical
management of AC patients was conducted over a 2-year
period in Belgium. Operative features and patients’ clinical
outcome were recorded. The impact of independent pre-
dictive factors on the choice of surgical approach, the
risk of conversion, and the occurrence of postoperative
complications was studied by multivariate logistic regres-
sion analysis.
Results Fifty-three surgeons consecutively and anony-
mously included 1,089 patients in this prospective study. A
primary open approach was chosen in 74 patients (6.8%),
whereas a laparoscopic approach was the first option in
1,015 patients (93.2%). Independent predictive factors for a
primary open approach were previous history of upper
abdominal surgery [odds ratio (OR) 4.13, p\ 0.001],
patient age greater than 70 years (OR 2.41, p\ 0.05),
surgeon with more than 10 years’ experience (OR 2.08,
p = 0.005), and gangrenous cholecystitis (OR 1.71,
p\ 0.05). In the laparoscopy group, 116 patients (11.4%)
required conversion to laparotomy. Overall, 38 patients
(3.5%) presented biliary complications and 49 had other
local complications (4.5%). Incidence of bile duct injury
was 1.2% in the whole series, 2.7% in the open group, and
1.1% in the laparoscopy group. Sixty patients had general
complications (5.5%). The overall mortality rate was 0.8%.
All patients who died were in poor general condition
[American Society of Anesthesiologists (ASA) III or IV].
Conclusions Although laparoscopic cholecystectomy is
currently considered as the standard treatment for acute
cholecystitis, an open approach is still a valid option in
more advanced disease. However, overall mortality and
incidence of bile duct injury remain high.
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Surgical management of patients suffering from acute
cholecystitis (AC) includes early or delayed cholecystec-
tomy and in selected high-risk patients percutaneous cho-
lecystostomy. Because of its safety and shortened hospital
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stay, early laparoscopic cholecystectomy (LC) has come to
be considered the standard treatment of AC [1–3].
Although an open approach remains a valid option in
complicated cases (e.g., gangrenous cholecystitis, etc.), LC
is reportedly safe and beneficial according to most series
[4–8]. As the latter are issued from experts, they may not
reflect general surgical practice, in particular regarding
overall mortality and biliary complication rate. The
Belgian Group for Endoscopic Surgery (BGES) therefore
conducted a prospective national survey among the general
community of surgeons in Belgium concerning the surgical
approach of AC, feasibility and results of LC in an acute




A prospective multicentric study was conducted over a
2-year period among members of the Belgian Group for
Endoscopic Surgery and the Royal Belgian Society of Sur-
gery concerning surgical management of patients suffering
from AC in Belgium. The study was designed as open
inclusion of all consecutive AC patients with a view to
analyzing common practice, results of each surgical
approach, predictive factors of mortality, morbidity
(including bile duct injury), and conversion rate of general
surgeons in Belgium.
Preliminary hypotheses included that:
1. Laparoscopy was the primary approach for operating AC
2. Conversion rate was significant (estimated range 10–20%)
3. The rate of bile duct injury (BDI) was also significant
(estimated above 0.5%), in reference to a previous
national survey [9]
There were 86 participating surgeons, 53 (62%) of
whom accepted to include their consecutive AC patients
into the study. A total of 35 hospitals were involved,
including 7 academic and 28 peripheral hospitals. A
detailed questionnaire was used for each patient, and a
computerized database was created. To improve the quality
of data self-reported by the participating surgeons, anon-
ymous data inclusion was guaranteed by the scientific
coordinator of the study. Each participating surgeon could
furthermore view his own results in comparison with the
whole series but had no access to results of other surgeons.
Definition of variables
Diagnosis of AC was based on preoperative clinical fea-
tures (fever, acute right upper quadrant abdominal pain
with tenderness or guarding, and/or inflammatory mass),
biological features [C-reactive protein (CRP) greater than
0.8 mg/dl and/or white blood cell count (WBCC) greater
than 10.000/mm3], ultrasonographic features (positive so-
nographic Murphy sign and gallbladder wall thickness
[4 mm and/or pericholecystic fluid), along with confir-
mation of AC by the surgeon during surgical exploration.
At final pathological examination, the following criteria
were considered for the diagnosis of AC: mucosal and
transmural infiltration of polymorphonuclear neutrophils
with alteration of the mucosa such as necrosis or hemor-
rhage. Severity of AC was based on intraoperative patho-
logical features. Edematous cholecystitis was defined as
gallbladder wall edema and hyperemia, empyema as a pus-
filled gallbladder with acutely inflamed and suppurative
walls, and gangrenous cholecystitis as frank necrosis/gan-
grene of the gallbladder wall [10].
Study data analysis was based on variables relating to the
patient, disease history, surgeon, and surgical procedure.
Patient-related variables included age, sex, comorbidity
according to American Society of Anesthesiologists (ASA)
physical score, and previous history of upper abdominal
surgery. Disease-related variables included clinical param-
eters such as type and duration of conservative medical
treatment before LC, history of stone migration, presence of
associated common bile duct stones (CBDS), need for pre-
operative endoscopic sphincterotomy (ES), biological
parameters (e.g., CRP,WBCC), and pathological parameters
(edematous or gangrenous cholecystitis, empyema). Sur-
geon-related variables included overall surgical experience
(defined as surgical practice duration since certification) and
laparoscopic experience with LC (defined as number of
operated LC). Surgical procedure-related variables included
the ‘‘intent-to-treat’’ type of approach (primarily open or
laparoscopic), delay between first symptoms of AC and the
operation, performance and results of intraoperative chol-
angiography (IOC), presence of CBDS or biliary anomaly at
IOC, performance of subtotal cholecystectomy, need for
conversion to open approach, and finally use of biliary or
peritoneal drainage.
Definition of endpoints
Evaluation criteria included conversion rate, hospital
mortality, complication rates (overall, local, and general),
mean operating time, length of postoperative hospital stay,
and need for reoperation or hospital readmission. Local
complications included bile duct injury (BDI), biliary fis-
tula, intraabdominal bleeding or abscess, and wound
complications (evisceration, abscess, hematoma, etc.). BDI
was defined as any injury to the main biliary tree; post-
operative biliary fistula was defined as biliary leakage from
an accessory bile duct (cystic or Luschka ducts). General
Surg Endosc (2012) 26:2436–2445 2437
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complications included urinary complications (cystitis,
retention), cardiac complications (failure, infarction), pul-
monary complications (infection, acute respiratory distress
syndrome), deep/superficial venous thrombosis, renal
insufficiency, delirium, upper gastrointestinal (GI)-tract
hemorrhage, etc. All evaluation criteria were assessed
within a postoperative period of 3 months. No further
follow-up was available.
Statistical analysis
Comparison of continuous variables was made using var-
iance analysis, Student’s t test, logarithmic transformation
or the Wilcoxon test when distribution was not normal. A
chi-square test was used for comparison of proportions. A
p value\0.05 was considered statistically significant. The
impact of each variable, such as independent predictive
factors, on the type of approach, conversion, postoperative
hospital stay, mortality, postoperative complications (local
and general), bile duct injury, and fistula was tested using
multivariate logistic regression. All covariates were intro-
duced into the model.
Results
Analysis of patient groups
In total, 1,089 consecutive patients suffering from AC took
part in the present study. Clinical, biological, disease-
related, surgeon-related, and surgical procedure-related
features of the whole series are presented in Table 1. The
results were analyzed according to each treatment option.
A primary open approach for cholecystectomy was chosen
in 74 patients (6.8%) (open group, OG) and an intent-to-
treat laparoscopic approach was the first option in 1,015
patients (laparoscopic group, LG) (93.2%) (Table 2).
Cholecystectomy was successfully accomplished by lapa-
roscopy in 899 of 1,015 patients (88.6%) (successful lap-
aroscopic group, SLG). Conversion to open approach was
required in 116 patients (11.4%) (converted group, CG)
(Table 3). Finally, pre- and perioperative features were
analyzed according to the delay between the onset of AC
and surgery (Table 4). Pathological examination of the
specimen was obtained for 1,033 patients. The gallbladder
specimens were mostly reported to show signs of edema-
tous cholecystitis in 730 cases (70.7%), of gangrenous
cholecystitis (n = 259, 25.1%), and empyema (n = 43,
4.2%). There were significantly more cases with empyema
and gangrenous cholecystitis in the OG (31/74, 41.9%)
than in the LG (271/958, 28.3%) (p = 0.013) (Table 2).
There was one gallbladder carcinoma.
Table 1 Patients’ clinical, biological, and disease-related, surgeon-
related, and surgical procedure-related features of the whole series of
1,089 patients operated for acute cholecystitis
Clinical features
Number of patients 1,089
Sex ratio (F/M) 1.35 (626/463)
Age, mean ± SD (years) 61.9 ± 15.7
ASA score III and IV 175 (16.1%)
Previous history of upper
abdominal surgery
119 (10.9%)
History of stone migration 201 (18.5%)
Coexistent CBDS 75 (6.9%)
Need for ERC and ES 246 (22.6%)
Biological features
CRP, mean ± SD (mgr/dl) 10.1 ± 12.3
WBCC, mean ± SD (9 103/mm3) 12.1 ± 8.4
Disease-related features
Need for percutaneous cholecystostomy 11 (1%)
Duration of initial medical
treatment, mean ± SD (days)
4.7 ± 8.9
Edematous cholecystitis at pathology 730 (70.7%)




mean ± SD (years)
11.1 ± 7.3
Laparoscopic experience with LC
\100 cases 95 (8.7%)
100–500 cases 286 (26.3%)
[500 cases 708 (65.0%)
Surgical procedure-related features
Delay of surgery:
Operation within 4 days 492 (46.6%)
Operation between 4 days and 6 weeks 351 (33.3%)
Operation after 6 weeks 212 (20.1%)
Primary open approach 74 (6.8%)
Primary laparoscopic approach 1,015 (93.2%)
Operative time, mean ± SD (min) 87 ± 38
Need for conversion
of LC to open approach
116 (11.4%)
IOC performance 545 (50.0%)
CBDS at IOC 75 (13.8%)
Biliary anomaly at IOC 27 (2.6%)
Subtotal cholecystectomy 29 (2.7%)
Biliary drainage 48 (4.4%)
Abdominal drainage 833 (76.5%)
AC acute cholecystitis, ASA American Society of Anesthesiologists,
CBDS common bile duct stone, CRP C-reactive protein, ERC endo-
scopic retrograde cholangiography, ES endoscopic sphincterotomy,
IOC intraoperative cholangiography, LC laparoscopic cholecystec-
tomy, SD standard deviation, WBCC white blood cell count
2438 Surg Endosc (2012) 26:2436–2445
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Choice of surgical approach
Although most patients (708/1,089) were operated upon by
experienced surgeons ([500 LC), 286 (26.3%) were
operated by surgeons having performed between 100 and
500 LC, and 95 patients (8.7%) by surgeons having fewer
than 100 LC. Univariate statistical comparison of patient-
related, disease-related, surgeon-related, and surgical pro-
cedure-related variables between OG and LG is detailed in
Table 2. The OG included more males, older patients with
higher operative risk, more patients with previous history
of upper abdominal surgery, more associated CBDS, and
more severe cholecystitis. In the OG, patients were more
frequently treated preoperatively by percutaneous chole-
cystostomy and operated upon by surgeons having per-
formed fewer than 100 LC, most often at a delay between
4 days and 6 weeks, and by using more frequently biliary
or abdominal drainage. Independent predictive factors of
primary open approach were found on multivariate analysis
to be the following: previous history of upper abdominal
surgery [OR 4.13, confidence interval (CI) 2.35–7.23,
p\ 0.001], patient age more than 70 years (OR 2.41, CI
1.44–4.01, p\ 0.05), surgeons with more than 10 years’
experience (OR 2.08, CI 1.24–3.49, p = 0.005), and




patients operated on primarily
through open (OG) or
laparoscopic approach (LG)
AC acute cholecystitis, ASA
American Society of
Anesthesiologists, CBDS








NS not significant, SD standard








Number of patients 74 1,015
Sex ratio (F/M) 0.72 (31/43) 1.4 (595/420) 0.005
Age, mean ± SD (years) 71.49 ± 16.63 62.43 ± 16.02 \0.001
ASA score III and IV 22 (29.7%) 153 (15.1%) 0.009
History of previous upper abdominal surgery 23 (31.1%) 96 (9.5%) \0.001
History of stone migration 18 (24.3%) 183 (18.0%) NS
Associated CBDS 11 (14.9%) 64 (6.3%) 0.005
Need for ERC and ES 19 (25.7%) 227 (22.4%) NS
Biological features
CRP, mean ± SD (mgr/dl) 13.8 ± 12.7 9.1 ± 11.7 0.001
WBCC, mean ± SD (9 103/mm3) 12.8 ± 6.9 11.2 ± 5.2 0.013
Disease-related features
Percutaneous cholecystostomy 4 (5.4%) 7 (0.7%) \0.001
Duration of initial medical treatment, mean ± SD (days) 7.0 ± 21.21 4.7 ± 8.9 NS
Edematous cholecystitis at pathology 43 (58.1%) 687 (71.7%) 0.01
Gangrenous cholecystitis or empyema at pathology 31 (41.9%) 271 (28.3%) 0.013
Surgeon-related features
Overall surgeon’s experience, mean ± SD (years) 12.9 ± 7.3 11.1 ± 7.3 NS
Laparoscopic experience with LC
\100 cases 13 (17.6%) 82 (8.1%) 0.005
100–500 cases 14 (18.9%) 272 (26.8%) NS
[500 cases 47 (63.5%) 661 (65.1%) NS
Surgical procedure-related features
Delay of surgery:
Operation within 4 days 35 (47.3%) 457 (46.6%) NS
Operation between 4 days and 6 weeks 34 (45.9%) 316 (32.2%) 0.015
Operation after 6 weeks 5 (6.8%) 207 (21.1%) 0.003
Operative time, mean ± SD (min) 98.27 ± 41.77 86.47 ± 37.42 0.001
Need for conversion of LC to open approach – 116 (11.4%) –
IOC performance 38 (51.3%) 507 (49.9%) NS
CBDS at IOC 11 (28.9%) 64 (12.6%) 0.005
Biliary anomaly at IOC 13 (34.2%) 14 (2.8%) \0.001
Subtotal cholecystectomy 4 (5.4%) 25 (2.5%) NS
Biliary drainage 13 (17.6%) 35 (3.4%) \0.001
Abdominal drainage 72 (97.3%) 761 (74.9%) \0.001
Surg Endosc (2012) 26:2436–2445 2439
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presence of gangrenous cholecystitis (OR1.71, CI 1.01–2.89,
p\ 0.05).
Timing of surgical approach
Fifty-four percent of the patients (586/1,089) received
antibiotics prior to cholecystectomy during a variable
period of time (mean 4.7 ± 8.9 days). Seventy percent of
patients had antibiotics in the preoperative period in the CG
(81/116 patients) and 51% in the SLG (461/899)
(p\ 0.001). There was no significant correlation between
duration of antibiotic therapy and risk of conversion or
complications.
Information about the delay between the first symptoms
of AC and operation was obtained for 1,055 patients. Early
operation, i.e., within 4 days, was performed for 492
patients (46.6%), whereas 351 patients (33.3%) had cho-
lecystectomy 4 days to 6 weeks after initial AC symptoms,
and 212 (20.1%) had delayed operation (after 6 weeks).
Preoperative percutaneous cholecystostomy was performed
in 11 patients (1.0%).
Surgical procedure-related features
Mean operating time was 98 min in the OG and 86 min in
the LG (p = 0.001). IOC was performed in 50.0% of the
Table 3 Clinical, biological,
disease-related, surgeon-related,
and surgical procedure-related
features of patients successfully
treated by laparoscopy (SLG) or
converted to laparotomy (CG)
AC acute cholecystitis, ASA
American Society of
Anesthesiologists, CBDS








NS not significant, SD standard









Number of patients 899 116
Sex ratio (F/M) 1.55 (547/352) 0.7 (48/68) \0.001
Age, mean ± SD (years) 61.79 ± 16.14 67.39 ± 14.6 \0.001
ASA score III and IV 131 (14.6%) 22 (18.9%) NS
Previous upper abdominal surgery 79 (8.8%) 17 (14.7%) 0.04
History of stone migration 151 (16.8%) 32 (27.6%) 0.004
Associated CBDS 51 (5.7%) 13 (11.2%) 0.021
Need for ERC and ES 194 (21.6%) 33 (28.5%) NS
Biological features
CRP, mean ± SD (mgr/dl) 8.73 ± 11.48 12.54 ± 12.67 \0.001
WCC, mean ± SD (9 103/mm3) 11.715 ± 7.026 11.509 ± 6.392 NS
Disease-related features
Percutaneous cholecystostomy 7 (0.8%) 0 NS
Duration of initial medical treatment, mean ± SD (days) 4.7 ± 8.9 5.1 ± 8.9 NS
Edematous cholecystitis at pathology 624 (69.3%) 62 (53.9%) \0.001
Gangrenous cholecystitis at pathology 222 (24.7%) 51 (44.3%) \0.001
Surgeon-related features
Overall surgeon experience, mean ± SD (years) 15.53 ± 19.41 13.26 7.31 NS
Laparoscopic experience with LC
\100 59 (6.6%) 23 (19.8%) \0.001
100–500 238 (26.5%) 34 (29.3%) NS
[500 603 (67.1%) 58 (50.0%) NS
Surgical procedure-related features
Delay between first symptoms of AC and operation,
mean ± SD (days)
18.6 ± 48.1) 18.7 ± 24.8 NS
Operative time, mean ± SD (min) 82.04 ± 33.90 121.50 ± 44.37 \0.001
IOC performance 462 (51.4%) 45 (38.8%) 0.01
CBDS at IOC 51 (5.7%) 13 (11.2%) 0.02
Biliary anomaly at IOC 12 (1.3%) 2 (1.7%) NS
Subtotal cholecystectomy 16 (1.8%) 9 (7.8%) \0.001
Biliary drainage 23 (2.6%) 12 (10.3%) \0.001
Abdominal drainage 653 (72.6%) 108 (93.1%) \0.001
2440 Surg Endosc (2012) 26:2436–2445
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whole series (545/1,089), 51.4% of SLG patients (462/
899), 38.8% of CG patients (45/116), and 51.3% of OG
patients (38/74). Among the 545 patients who underwent
IOC, biliary anomaly was found in 27 patients (2.6%) and
CBDS was present in 75 patients (13.8%). However, 201
patients had clinical history of stone migration (18.5%).
Biliary drainage after CBD exploration was left in place in
4.4% (48/1,089). There were more cases with biliary
drainage in the OG (13/74, 17.6%) than in the LG (35/
1,015, 3.4%) (p\ 0.001). Abdominal drainage was placed
in 76.5% of patients (833/1,089), more frequently in the
OG (72/74, 97.3%) than in the LG (761/1,015, 74.9%)
(p\ 0.001). Subtotal cholecystectomy was performed in
2.7% of patients (29/1,089), 2.5% (25/1,015) in the LG,
and 5.4% (4/74 patients) in the OG [not significant (NS)]
(Table 2).
Conversion to laparotomy
Among the 1,015 patients, 116 patients required conversion
to laparotomy (11.4%), of whom 69 were males and 47
females. Conversion rate was 7.5% (47/626) for females
and 14.9% (69/463) for males. Mean delay from pneu-
moperitoneum to conversion was 36 min (5–128 min). The
reasons for conversion were, in decreasing frequency,
unclear anatomy and technical difficulties in 67 patients
(57.8%), suspicion of BDI in 9 (7.8%), bleeding in 8
(6.9%), unsuccessful stone extraction in 6 (5.2%), and
suspicion of gallbladder carcinoma in 3 (2.6%). Cancer
was confirmed by pathological examination for only one
case.
Clinical, biological, disease-related, surgeon-related,
and surgical procedure-related features in the SLG and CG
are presented in Table 3. In the CG, patients tended to be
men, be older, and have previous upper abdominal surgery,
associated CBDS, and more severe cholecystitis, and sur-
geons tended to be less experienced, took longer operating
time, and made greater use of IOC as well as subtotal
cholecystectomy, and biliary and peritoneal drainage.
Multivariate analysis indicated that patients who had a
significantly higher risk of being converted to laparotomy
were those who had preoperative antibiotics (OR 1.91, CI
1.20–3.04, p = 0.006), gangrenous cholecystitis (OR 2.07,
CI 1.34–3.21, p = 0.001), and associated CBD stone
migration (OR 1.99, CI 1.23–3.21, p = 0.005). Conversion
was also more frequent if the surgeon had less experience
(fewer than 500 LC) (OR 2.65, CI 1.71–4.10, p\ 0.001).
Surgeons having more than 10 years’ experience con-
vertedmore frequently to laparotomy (OR 2.47, CI 1.57–3.9,
p\ 0.001). Women under 65 years of age were less at risk
of requiring conversion (OR 0.26, CI 0.14–0.50, p\ 0.001).
Mortality and complication rates
Early and late postoperative outcome in the OG and LG are
reported in Table 5, as well as in the SLG and CG in
Table 6. Thirty-eight patients (3.5%) presented biliary
complications: 5 patients in the OG (2 BDI and 3 biliary
leaks) and 33 patients in the LG (11 BDI and 22 biliary
leaks). Incidence of biliary complications was higher in the
OG (6.8%) than in the LG (3.3%), but the difference was
not significant (p = 0.07). Overall incidence of BDI was
1.2% (13/1,089). BDI was more frequent in OG patients
(2.7%, 2/74) than in the LG (1.1%, 11/1,015), but the
difference was not significant (p = 0.40). In the OG, there
was one complete CBD transection and one partial injury









Mortality 3/354 (1.4%) 3/382 (0.8%) 1/206 (0.5%) NS
Complications
Overall 48/411 (11.7%) 40/430 (9.3%) 16/213 (7.5%) NS
Local 21/411 (5.1%) 20/430 (4.7%) 8/213 (3.75%) NS
General 27/411 (5.6%) 20/430(4.7%) 8/213 (3.75%) NS
Biliary complications
Bile duct injury 4/406 (1.0%) 7/426 (1.6) 2/212 (0.9%) NS
Biliary fistula 11/406 (2.7%) 10/426 (2.3%) 4/211 (1.9%) NS
Postoperative hospital stay, mean ± SD (days) 8.75 ± 26.55 11.59 ± 13.3 27.22 ± 40.61 NS
3-Month postoperative outcome
Readmission 5/354 (1.4%) 13/390 (3.3%) 5/205 (2.4%) NS
Reoperation 5/354 (1.4%) 9/390 (2.3%) 3/205 (1.5%) NS
NS not significant, SD standard deviation
Surg Endosc (2012) 26:2436–2445 2441
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of the right hepatic duct. In the LG, there were two com-
plete CBD transections and nine partial CBD injuries of
which three occurred after conversion and four before
conversion. Multivariate logistic regression analysis indi-
cated that conversion was the only factor associated with
BDI (p\ 0.001).
Forty-nine patients (4.5%) had other local complications
including 31 wound complications, 7 intra-abdominal
hemorrhages, 3 intra-abdominal abscesses, 7 residual CBD
stones, and 1 biochemical pancreatitis. The wound com-
plication rate was 10.8% (8/74) in the OG compared with
2.3% (23/1,015) in the LG (p\ 0.001), and it was signif-
icantly lower in the SLG (1.6%, 14/899) than in the CG
(7.8%, 9/116) (p\ 0.001). Predictive factors identified on
multivariate logistic regression were associated CBD stone
migration (OR 2.00, CI 1.03–3.87, p = 0.04) and conver-
sion (OR 3.94, CI 2.04–7.65, p\ 0.01).
Overall, 60 patients had general complications (5.5%):
cardiac failure (n = 3), myocardial ischemia (3), cardiac
arrhythmia (2), pulmonary infections (11), pleural effusion
(1), acute respiratory distress syndrome (ARDS) (1), stroke
(2), deep/superficial vein thrombosis (3), renal failure (6),
urinary infection (5), urinary retention (6), septicemia (4),
hyperthermia (4), upper GI-tract hemorrhage (1), gastro-
enteritis (4), hepatitis (3), anemia (2), delirium (1), and
others (4). The risk factors for general complications
identified on multivariate logistic regression analysis were
observed to be ASA score III or IV (OR 4.2, CI 4.40–7.68,
p\ 0.01) and gangrenous cholecystitis (OR 3.0, CI
1.69–5.34, p\ 0.001).
Mortality rate was 0.8% overall (9/1,089), all occurring
in patients in poor general condition (ASA III or IV). The
causes of death were sepsis (n = 4), multiple organ failure
(2), cardiopulmonary dysfunction (2), and stroke and
Table 5 Comparison of early
and 3-month postoperative
outcome of patients operated
primarily through open (OG) or
laparoscopic approach (LG)








Mortality (%) 4 (5.4%) 5 (0.5%) \0.001
General complications (%) 3 (4.1%) 57 (5.6%) NS
Biliary complications (%) 5 (6.8%) 33 (3.3%) 0.07
Bile duct injury 2 11
Biliary fistula 3 22
Other local complications (%) 8 (10.8%) 41 (4.0%) 0.007
Reoperation (%) 4 (5.4%) 10 (1.0%) 0.001
Postoperative hospital stay, mean ± SD (days) 12.0 ± 9.3 6.0 ± 13.3 0.01
3-Month postoperative outcome
Late complications (%) 1 (1.4%) 17 (1.7%) NS
Readmission (%) 2 (2.7%) 13 (1.3%) NS
Table 6 Comparison of early
and 3-month postoperative
outcome of patients successfully
operated using laparoscopic
approach (SLG) or converted to
open surgery (CG)
NS not significant, SD standard
deviation
Successful laparoscopic
group (SLG) N = 899
Converted group
(CG) N = 116
p Value
Early postoperative outcome
Mortality (%) 4 (0.44%) 1 (0.08%) NS
Overall complications (%) 106 (11.79%) 37 (31.89%) \0.001
General complications (%) 48 (5.33%) 9 (7.76%) NS
Biliary complications (%) 17 (1.89%) 16 (13.79%) \0.001
Bile duct injury (%) 4 7
Biliary fistula (%) 13 9
Other local complications (%) 26 (2.89%) 15 (12.93%) \0.001
Reoperation (%) 8 (0.89%) 2 (1.72%) NS
Postoperative hospital stay, mean ± SD (days) 5.5 ± 13.8 10.0 ± 6.4 0.03
3-Month postoperative outcome
Late complications (%) 14 (1.55%) 3 (2.58%) NS
Readmission (%) 11 (1.22%) 2 (1.72%) NS
2442 Surg Endosc (2012) 26:2436–2445
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hemorrhage from the liver bed (1). Five patients died in the
LG (0.5%) and four in the OG (5.4%) (p\ 0.001). Pre-
dictive factors of mortality were found on multivariate
logistic regression to be occurrence of postoperative gen-
eral complications and initial choice of open approach
(p\ 0.001).
Four of 74 OG patients (5.4%) had to be reoperated,
versus 10 of 1,015 LG patients (1.0%, p = 0.001). There
was no statistical difference concerning the reintervention
rate between CG and SLG.
Mean postoperative hospital stay was 12.0 ± 9.3 days
for OG patients and 6.0 ± 13.3 days for LG patients
(p = 0.01). Mean postoperative hospital stay was
10.0 ± 6.4 days for the CG and 5.5 ± 13.8 days for the
SLG (p = 0.03).
At 3 months postoperatively, there was no statistical
difference between the different groups (OG versus LG and
SLG versus CG) in terms of either late complications or
readmission rates. Finally, the delay between the first
symptoms of AC and LC influenced neither the early
mortality and complication rates nor the 3-month outcome
(Table 4).
Discussion
In this multicenter Belgian national survey, all patients were
included consecutively, reflecting the common practice of
general surgeons in Belgium rather than only the practice of
expert centers. The choice between open and laparoscopic
approach was left to the discretion of each of the 53 partic-
ipating surgeons. Most importantly, the data were included
anonymously, thereby improving the reliability of the results
and providing a clear overall representative picture of sur-
gical management of AC in Belgian hospitals.
In the present study, primary open cholecystectomy was
chosen by surgeons for cases in which the patient was
older, had a history of previous upper abdominal surgery,
when gangrenous cholecystitis was suspected, and when
surgeons had more than 10 years’ experience. In the latter
situation, primary open approach was probably considered
as more careful practice. Additionally, surgeons having
more than 10 years’ experience and surgeons having per-
formed fewer than 500 LC converted more frequently. This
could mean that, with experience, surgeons identified risks
more rapidly during LC, while surgeons less skilled in
laparoscopic techniques recognized that the laparoscopic
approach might be technically too demanding in difficult
cases of AC and preferred conversion to a primary open
approach [3, 11–14]. Local disease-related factors, such as
gangrenous cholecystitis or coexistent CBDS, were major
predictive factors of conversion, in agreement with previ-
ous reports [13, 14]. Surprisingly, women under the age of
65 years were less at risk of requiring conversion
(p\ 0.001). Whether this was because of cosmetic reasons
or because men had a higher rate of complicated AC is
unclear. Indeed, it has been reported that inflammation and
fibrosis are more extensive in men than in women, which
could explain a higher conversion rate [15]. Similarly, men
and older patients have higher conversion and complication
rates [16]. The overall conversion rate was 11.4% in the
present study (7.5% for men and 14.9% for women),
without increased mortality but with increased local com-
plication rates and longer hospital stay.
In cases where a primary laparoscopic approach was
chosen, there was no relationship between preoperative
medical treatment and either conversion or complication
rates, essentially because of a great variability in the delay
before LC [standard deviation (SD): 8.9 days]. On the other
hand, patients treated preoperatively with antibiotics
(regardless of treatment duration) were at higher risk of
requiring conversion. This may be linked to the fact that
decision to give preoperative antibiotics may be related to
disease severity. In their recent systematic review of ran-
domized controlled trials, Gurusamy et al. report that there
was no significant difference between early and delayed
cholecystectomy for AC in terms of BDI or conversion to
open cholecystectomy, although total hospital stay was
shorter by 4 days in the early patient group. Furthermore,
17.5% of the patients who underwent the delayed surgical
approach were operated as an emergency because of non-
resolving or recurrent cholecystitis [2]. The overall com-
plication rate was shown in a previous study to be
statistically higher if the delay before operation was more
than 4 days (19.8% versus 13.3%), as was the local com-
plication rate (13.2% versus 6.5%) [4]. In the present sur-
vey, there was no difference in complication rate between
early and delayed cholecystectomy groups. However, sev-
eral meta-analyses and controlled trials recommend early
operation for AC [2, 17, 18].
In the present study, overall incidence of BDI was, as
expected, significantly higher (1.2%) than in previously
reported national surveys of LC. Nuzzo et al. reported in a
multicenter national series an overall BDI incidence of
0.56% in cholecystitis, significantly higher than 0.32% in
simple cholelithiasis [19]. In two other national multicenter
studies including both acute and elective cases, BDI rates
were 0.5 and 0.25%, respectively [20, 21]. Cholecystitis
must be considered as a risk factor for BDI, as shown by
Gigot et al. in a previous national survey of 65 BDI in
Belgium [9] in which AC and scleroatrophic gallbladder
were present in half of patients. Because of the anonymous
inclusion of patients in the present study, the BDI inci-
dence of 1.2% is probably a closer reflection of reality.
However, we must also take into consideration the signif-
icant rate of postoperative biliary fistula, which can hide
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some unrecognized BDI as reported in the literature. A key
message from the present study is that, contrary to usual
consideration, conversion to open approach during LC for
AC is not a guarantee to avoid BDI, since three BDI
occurred after conversion. This is important from the
medicolegal point of view. On the contrary, four BDI were
discovered during conversion while having occurred and
been suspected during the laparoscopic phase of the oper-
ation. In 7.8% of the converted cases in the present series
the reason was BDI suspicion.
The opinion of the surgical community regarding per-
formance of IOC during LC is torn between the idea that
routine IOC does not help prevent BDI [19] and the idea
that the rate of CBD injury is significantly lower when IOC
is used [21]. Like Suter et al., the authors believe that,
especially in case of AC, IOC is strongly recommended
because it helps to clarify the anatomy and allows early
diagnosis and repair of BDI [9, 22].
Subtotal cholecystectomy has been reported as a good
alternative to classic cholecystectomy to reduce the risk of
BDI and conversion in patients with technically difficult
operation for severe cholecystitis [23–27]. Surprisingly, in
the current series, subtotal cholecystectomy was performed
in only 2.7% of patients. In a study of 39 patients with
severe cholecystitis and difficult local conditions, Hubert
et al. reported the safety of the endovesicular approach
with subtotal cholecystectomy for gallbladder dissection as
an alternative to the classic Calot’s triangle dissection. In
their series there were no postoperative biliary or infectious
complications [26].
In a randomized trial comparing open versus LC for AC,
Johansson et al. found no significant differences in the rate
of postoperative complications [28]. In the present study,
the wound infection rate was significantly higher in the OG
than in the LG (10.8% versus 2.3%). As reported by other
authors [8], this may be due to the fact that patients treated
by open surgery were significantly older, were at greater
operative risk, and had more severe biliary disease than
patients treated laparoscopically. According to our multi-
variate analysis, CBD stone migration and conversion to
laparotomy were identified as risk factors for local com-
plications. The passage of a stone through the cystic duct
may produce inflammation or fibrosis in Calot’s triangle,
making identification of important anatomical landmarks
more difficult and thereby increasing the risk of BDI, bil-
iary fistula, bleeding, or conversion to laparotomy. The
overall mortality rate was 0.8% in the present surgical
series. All operated patients who died were in poor general
condition with significant comorbidities (ASA III or IV).
The mortality rate was significantly higher in the primary
open approach but not in the converted group. Practically,
AC remains a severe and potentially lethal disease [27, 29],
especially in elderly and high-risk patients.
In conclusion, primary laparoscopic approach was con-
sidered by Belgian surgeons as the standard approach in
93.2% of AC. Primary open approach or conversion
remained alternative options. The conversion rate was as
expected at 11.4% and was related to various patient, dis-
ease, and surgeon features. The risk of BDI in AC was high
(1.2%), and although the present survey was not compar-
ative, this was higher than in a previous national Belgian
survey. Finally, use of subtotal cholecystectomy is also a
good option in case of dangerous dissection of a severely
inflamed Calot’s triangle.
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